Glyceryltriacetate (GTA) for use in improving breathing
AssigneeYissum Research Development Company of the Hebrew University of Jerusalem
InventorShmuel Ben-Sasson
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to glyceryltriacetate (GTA) compound for use in improving breathing in a subject experiencing a breathing difficulty. Of particular interest is the use of GTA for treating reduced lung function, such as that caused by lung infection and/or lung inflammation. Also disclosed is thus a composition and method for improving breathing of a subject experiencing a breathing difficulty.
Claims18
A method of improving breathing of a subject suffering from a lung disease or disorder associated with reduced lung function that causes a breathing difficulty in the subject, said method comprising administering to the subject an amount of glyceryltriacetate (GTA), the amount being effective to improve breathing in the subject.
Dependencies are inferred from the claim text.